Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL309120 | 1.00 | KDM4E (0.54) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL12595128 | 0.89 | KDM4E (0.47) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL2880789 | 0.85 | KDM4E (0.39) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL2879274 | 0.84 | APP (0.42) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL269261 | 0.84 | HRH4 (0.43) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL269262 | 0.84 | HRH4 (0.43) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL14010594 | 0.84 | ALDH1A1 (0.38) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL8652709 | 0.84 | APP (0.42) | KDM4EALDH1A1MAPTCYP1A2MAPK1 | |
| SCHEMBL79976 | 0.83 | PDE5A (0.42) | KDM4EALDH1A1NPC1RAB9AHRH4 | |
| SCHEMBL79977 | 0.83 | PDE5A (0.42) | KDM4EALDH1A1NPC1RAB9AHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| EP-2154162-B1 | REACTIVE URETHANE COMPOUND HAVING ETHER BOND, CURABLE COMPOSITION AND CURED MATERIAL | SHOWA DENKO KK (JP) | 2019-07-17 | — | — | EP | disclosed |
| EP-2356182-B1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2015-05-06 | — | — | EP | disclosed |
| US-20130299736-A1 | RADIATION-CURABLE COATING MATERIALS | BASE SE (DE) | 2013-11-14 | — | — | US | disclosed |
| US-8399569-B2 | Reactive urethane compound having ether bond, curable composition, and cured material | SHOWA DENKO K.K. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-1866357-B1 | (METH)ACRYLOYL GROUP-CONTAINING AROMATIC ISOCYANATE COMPOUND AND PRODUCTION PROCESS THEREOF | SHOWA DENKO KK (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-8092982-B2 | Photosensitive paste composition, barrier rib prepared using the composition and plasma display panel comprising the barrier rib | SAMSUNG SDI CO., LTD. (KR) | 2012-01-10 | — | — | US | disclosed |
| US-8044235-B2 | (Meth) acryloyl group-containing aromatic isocyanate compound and production process thereof | SHOWA DENKO K.K. (JP) | 2011-10-25 | — | — | US | disclosed |
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | BASF SE (DE) | 2011-09-22 | — | — | US | disclosed |
| EP-2356182-A1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2011-08-17 | — | — | EP | disclosed |
| EP-0915136-B1 | Photocurable paint composition for road markings | SHOWA DENKO KK (JP) | 2004-01-21 | — | — | EP | disclosed |
| US-6486225-B1 | Photocurable composition | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2002-11-26 | — | — | US | disclosed |
| US-6211260-B1 | MARKING ROADS WITH CURABLE PAINT, FILLERS, GLASS BEADS, CATIONIC DYES AND QUATERNARY ORGANIC BORATES | SHOWA DENKO K.K. (JP) | 2001-04-03 | — | — | US | disclosed |
| US-6190833-B1 | (A) A PHENOL RESIN, (B) AN AMINO RESIN, (C) A COMPOUND HAVING TWO OR MORE CROSSLINKING GROUPS IN A MOLECULE, AND (D) A HALOMETHYL-1,3,5-TRIAZINE COMPOUND. | JSR CORPORATION (JP) | 2001-02-20 | — | — | US | disclosed |
| US-6110987-A | CURED PRODUCTS HAVING AN EXCELLENT APPEARANCE WITHOUT COLORING CAUSED BY POLYMERIZATION INITIATOR | SHOWA DENKO K.K. (JP) | 2000-08-29 | — | — | US | disclosed |
| EP-1002817-A2 | Photocurable composition | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2000-05-24 | — | — | EP | disclosed |
| EP-0915136-A1 | Photocurable paint composition for road markings | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1999-05-12 | — | — | EP | disclosed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| EP-0165006-A2 | Processes for preparing substituted halomethyl-s-triazines | Polychrome Corporation (US) | 1985-12-18 | — | — | EP | disclosed |
| US-4559401-A | Process for preparing chromophore-substituted vinyl-halomethyl-s-triazines | POLYCHROME CORPORATION (US) | 1985-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | RAD51, MGMT, RAD54L | KDM4E 1273/4885ALDH1A1 2704/4885MAPT 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.